Amplify Weight Loss Drug & Treatment ETF
Limited financial coverage for THNR.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.
- IPO
- 2024
- HQ
- Lisle, IL, US
Get TickerSpark's AI analysis on THNR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.91M
- Div Yield
- 1.67%
- 52W High
- $27.94
- 52W Low
- $22.89
- 50D MA
- $26.06
- 200D MA
- $25.41
- Beta
- 0.43
- RSI (14)
- 38
- Avg Volume
- 1.36K
No earnings-call transcripts are available for THNR yet.
- Free Float
- 100.0%
- Shares Outstanding
- 199.99K
- Float Shares
- 199.99K
of shares held by institutions
4 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Citadel Advisors LLC | 27.49K | ▲ 252 |
| Jane Street Group, LLC | 17.51K | ▲ 17.51K |
| Advisor Group Holdings, Inc. | 356 | ▲ 356 |
| Godfrey Financial Associates, Inc. | 203 | 0 |
Our THNR coverage
Recent articles, reports, and earnings notes.
No research on THNR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate THNR report →Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win
zacks.com · Oct 1
Who Are You Calling Passive? Many Index ETFs Dynamically Rebalanced in September
etftrends.com · Sep 28
NTHM's Index Rebalance Puts Thematic Rotation to Work
etftrends.com · Sep 25
THNR's Weight-Loss Index Swaps Hims & Hers for Gilead
etftrends.com · Sep 21
Inside THNR: A Leaner Approach to Weight Loss Investing
etftrends.com · Jul 7
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
zacks.com · Jul 1
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
etftrends.com · Jun 11
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
zacks.com · Jun 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.